1400 related articles for article (PubMed ID: 20086077)
1. Myocardial fatty acid metabolism in health and disease.
Lopaschuk GD; Ussher JR; Folmes CD; Jaswal JS; Stanley WC
Physiol Rev; 2010 Jan; 90(1):207-58. PubMed ID: 20086077
[TBL] [Abstract][Full Text] [Related]
2. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
Zhang L; Keung W; Samokhvalov V; Wang W; Lopaschuk GD
Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
[TBL] [Abstract][Full Text] [Related]
3. Targets for modulation of fatty acid oxidation in the heart.
Lopaschuk GD
Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
[TBL] [Abstract][Full Text] [Related]
4. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Dec; 1862(12):2211-2220. PubMed ID: 27479696
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Energy Metabolism in Heart Failure.
Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
[TBL] [Abstract][Full Text] [Related]
6. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
7. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy.
Fillmore N; Mori J; Lopaschuk GD
Br J Pharmacol; 2014 Apr; 171(8):2080-90. PubMed ID: 24147975
[TBL] [Abstract][Full Text] [Related]
9. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
Kerr M; Dodd MS; Heather LC
Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
[TBL] [Abstract][Full Text] [Related]
10. Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic.
Lopaschuk GD
Can J Cardiol; 1989 Sep; 5(6):315-20. PubMed ID: 2676122
[TBL] [Abstract][Full Text] [Related]
11. Metabolic toxicity of the heart: insights from molecular imaging.
Iozzo P
Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):147-56. PubMed ID: 20031381
[TBL] [Abstract][Full Text] [Related]
12. Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders.
Lopaschuk GD
Ann Nutr Metab; 2016; 68 Suppl 3():15-20. PubMed ID: 27931032
[TBL] [Abstract][Full Text] [Related]
13. Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart.
Bakrania B; Granger JP; Harmancey R
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768055
[TBL] [Abstract][Full Text] [Related]
14. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid oxidation in the heart.
Grynberg A; Demaison L
J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S11-7. PubMed ID: 8891866
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical role of lipid metabolism in heart function and dysfunction.
Dhalla NS; Elimban V; Rupp H
Mol Cell Biochem; 1992 Oct; 116(1-2):3-9. PubMed ID: 1480151
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid oxidation in the reperfused ischemic heart.
Kantor PF; Dyck JR; Lopaschuk GD
Am J Med Sci; 1999 Jul; 318(1):3-14. PubMed ID: 10408755
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
Fukushima A; Milner K; Gupta A; Lopaschuk GD
Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
[TBL] [Abstract][Full Text] [Related]
19. Regulation of energy substrate metabolism in the diabetic heart.
Stanley WC; Lopaschuk GD; McCormack JG
Cardiovasc Res; 1997 Apr; 34(1):25-33. PubMed ID: 9217869
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
